Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ainos, Inc. (AIMD : NSDQ)

• Company Description    Ainos, Inc. has evolved from a niche biotechnology and medical diagnostics developer into a company pioneering a new category of artificial intelligence known as SmellTech or Smell AI. Centered on its flagship AI Nose platform, Ainos digitizes scent into machine-readable Smell ID data for intelligent sensing applications across robotics, smart manufacturing, semiconductors and healthcare infrastructure, while maintaining selective legacy therapeutic programs. Ainos is incorporated in Texas. Number of Employees: 41

• Price / Volume Information    Yesterday's Closing Price: $1.35 Daily Weekly Monthly 20 Day Moving Average: 351,992 shares Shares Outstanding: 7.38 (millions) Market Capitalization: $9.99 (millions) Beta: 2.47 52 Week High: $4.44 52 Week Low: $1.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.44% -15.48% 12 Week -28.41% -29.78% Year To Date -17.50% -26.87%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3050 POST OAK BLVD SUITE 510-T80 - HOUSTON,TX 77056 USA ph: 281-898-6586 fax: 806-376-9301 ir@ainos.com http://www.ainos.com

• General Corporate Information    Officers Chun-Hsien Tsai - Chief Executive Officer; Chairman and President Hsin-Liang Lee - Chief Financial Officer Wen-Han Chang - Director Yao-Chung Chiang - Director Pao-Sheng Wei - Director Peer Information Ainos, Inc. (CHCR) Ainos, Inc. (ESRX) Ainos, Inc. (MYDP) Ainos, Inc. (COR) Ainos, Inc. (GBCS) Ainos, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 00902F402 SIC: 3577 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 7.38 Most Recent Split Date: 6.00 (0.20:1) Beta: 2.47 Market Capitalization: $9.99 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.51 Price/Cash Flow: - Price / Sales: 80.57 EPS Growth vs. Year Ago Period: 37.37% vs. Previous Quarter: -51.22% Sales Growth vs. Year Ago Period: 2,940.00% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -217.50 03/31/26 - -160.55 ROA 09/30/26 - - 06/30/26 - -67.87 03/31/26 - -62.29 Current Ratio 09/30/26 - - 06/30/26 - 0.13 03/31/26 - 0.55 Quick Ratio 09/30/26 - - 06/30/26 - 0.12 03/31/26 - 0.50 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - -8,760.00 03/31/26 - -77,466.66 Book Value 09/30/26 - - 06/30/26 - 0.39 03/31/26 - 0.78 Inventory Turnover 09/30/26 - - 06/30/26 - 0.01 03/31/26 - 0.02 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 1.58 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 61.26

Powered by Zacks Investment Research ©